Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NH › Manchester › NPI 1528150273
Hospital

Catholic Medical Center

Catholic Medical Center was paid $19.82M by Medicaid between Jan 2018 and Dec 2024, across 265 billing codes. Its largest line is 99285, emergency room visit (most serious) — 17% of everything it billed.

33Billing provider infoCATHOLIC MEDICAL CENTER
MANCHESTER, NH 03102
33aNPI1528150273assigned 09/29/2006
28Total paid$19.82M
24GClaims607,005
24DCodes billed265
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Psychiatric Hospital Unit providers in New Hampshire

Rank by total paid#1 of 5
Median peer was paid$54K
This provider vs. median365×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018118,854$2.82M
2019135,847$3.83M
202088,222$2.59M
2021112,514$3.87M
202288,232$3.61M
202335,619$1.70M
2024incomplete27,717$1.40M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 17% 15,810 12,499 $3.40M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 16% 17,254 14,356 $3.20M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.1% 13,170 11,375 $1.40M
74177 Computed tomography, abdomen and pelvis; with contrast material 6.4% 3,426 2,809 $1.26M
G0378 Hospital observation service, per hour 2.6% 4,412 3,221 $519K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2.3% 2,369 1,905 $463K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 2.3% 4,223 3,933 $448K
70450 Computed tomography, head or brain; without contrast material 2.2% 3,902 3,008 $444K
96361 Intravenous infusion, hydration; each additional hour 2.2% 7,600 4,815 $430K
96375 Therapeutic injection; each additional sequential IV push 2.1% 9,025 6,015 $421K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.9% 13,169 9,847 $384K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.7% 19,759 15,516 $340K
253 more codes
71046 Radiologic examination, chest; 2 views 1.6% 10,345 $324K
71275 Computed tomographic angiography, chest, with contrast material 1.5% 1,140 $290K
80053 Comprehensive metabolic panel 1.5% 45,085 $288K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.4% 8,367 $278K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.2% 5,889 $229K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.1% 876 $225K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.1% 45,829 $216K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.1% 8,303 $215K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 24,541 $183K
J2785 Injection, regadenoson, 0.1 mg <1% 719 $180K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 8,566 $175K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 3,091 $169K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 2,132 $158K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 248 $142K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 2,519 $133K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,932 $130K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 2,625 $124K
72125 Computed tomography, cervical spine; without contrast material <1% 946 $123K
93017 <1% 1,149 $121K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,274 $108K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,354 $99K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 737 $95K
84484 <1% 14,288 $94K
71045 Radiologic examination, chest; single view <1% 3,559 $87K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 212 $85K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,519 $83K
84443 Thyroid stimulating hormone (TSH) <1% 7,809 $80K
80061 Lipid panel <1% 7,951 $78K
93351 <1% 163 $78K
76801 <1% 816 $76K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,931 $74K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 3,734 $73K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,441 $71K
96376 <1% 2,389 $54K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,694 $53K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,688 $53K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 193 $53K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 938 $51K
84703 <1% 9,478 $49K
93320 <1% 608 $49K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 2,061 $49K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 4,061 $48K
93325 <1% 755 $45K
83880 <1% 2,659 $43K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 555 $41K
83036 Hemoglobin; glycosylated (A1C) <1% 5,955 $39K
93971 <1% 644 $39K
80048 Basic metabolic panel (calcium, ionized) <1% 7,612 $36K
97161 <1% 1,155 $35K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 212 $34K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 2,440 $34K
87631 <1% 356 $32K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,500 $32K
J2704 Injection, propofol, 10 mg <1% 4,854 $31K
J1650 Injection, enoxaparin sodium, 10 mg <1% 2,219 $29K
86850 <1% 3,840 $29K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 807 $29K
76830 Ultrasound, transvaginal <1% 399 $28K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,869 $28K
85027 <1% 6,313 $26K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 1,198 $25K
J1756 Injection, iron sucrose, 1 mg <1% 611 $25K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 206 $25K
80074 <1% 677 $25K
82728 <1% 2,478 $24K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 86 $23K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,597 $23K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,863 $22K
95811 <1% 44 $22K
72100 <1% 528 $22K
97803 <1% 1,092 $21K
83690 <1% 5,004 $21K
70551 Magnetic resonance imaging, brain; without contrast material <1% 85 $21K
87070 <1% 3,271 $21K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 668 $20K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 219 $20K
93246 <1% 322 $20K
97162 <1% 755 $18K
84702 <1% 1,492 $17K
81001 <1% 8,558 $16K
73630 <1% 576 $16K
87522 Neg quan hep c or qual rna <1% 507 $16K
J2469 Injection, palonosetron hcl, 25 mcg <1% 189 $16K
97597 <1% 475 $15K
82607 <1% 1,812 $15K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 36 $14K
71271 <1% 56 $14K
87040 <1% 1,673 $14K
36591 <1% 1,839 $14K
73030 <1% 497 $13K
86780 <1% 1,297 $13K
87186 <1% 2,244 $13K
99213 Doctor's office visit, returning patient (routine) <1% 1,242 $13K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 291 $12K
87077 <1% 2,340 $12K
83735 <1% 3,316 $12K
94060 <1% 224 $12K
99157 <1% 172 $12K
84439 <1% 1,858 $12K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 130 $11K
83550 <1% 1,777 $11K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,948 $10K
J1644 Injection, heparin sodium, per 1000 units <1% 1,853 $10K
85610 <1% 5,515 $10K
71250 <1% 79 $10K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 507 $10K
83540 <1% 2,055 $10K
36415 Collection of venous blood by venipuncture <1% 37,188 $9K
99156 <1% 200 $9K
73610 <1% 324 $9K
C1769 Guide wire <1% 221 $9K
82746 <1% 880 $9K
86803 <1% 906 $9K
87340 <1% 1,181 $9K
99214 Doctor's office visit, returning patient (more involved) <1% 270 $9K
81003 <1% 8,582 $9K
85379 <1% 1,321 $9K
83605 <1% 1,252 $8K
97535 Self-care/home management training, each 15 minutes <1% 551 $8K
80076 <1% 1,290 $8K
93296 <1% 1,518 $8K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,129 $7K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,022 $7K
94726 <1% 277 $7K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,266 $7K
94729 <1% 252 $7K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 264 $7K
97802 <1% 190 $7K
87081 <1% 1,470 $6K
A9585 Injection, gadobutrol, 0.1 ml <1% 347 $6K
86140 <1% 1,850 $6K
96415 <1% 242 $6K
86900 <1% 3,244 $6K
86901 <1% 3,357 $6K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,401 $5K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 653 $5K
73564 <1% 157 $5K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,681 $5K
99152 <1% 111 $5K
82043 <1% 1,195 $5K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 305 $5K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 730 $5K
80050 General health panel <1% 604 $4K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 271 $4K
J7030 Infusion, normal saline solution , 1000 cc <1% 1,234 $4K
85652 <1% 2,035 $4K
87205 <1% 1,429 $4K
86403 <1% 478 $4K
88342 <1% 310 $4K
86762 <1% 301 $3K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 31 $3K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 396 $3K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 117 $3K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 42 $3K
70498 <1% 12 $3K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 45 $3K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 748 $3K
86618 <1% 176 $3K
87634 <1% 109 $3K
A9578 Injection, gadobenate dimeglumine (multihance multipack), per ml <1% 119 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,835 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,889 $3K
73130 <1% 109 $3K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 41 $3K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,246 $3K
93970 <1% 33 $2K
76642 <1% 57 $2K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 19 $2K
99201 <1% 141 $2K
73502 <1% 97 $2K
73562 <1% 99 $2K
86481 <1% 52 $2K
99153 Mod sedat endo service >5yrs <1% 47 $2K
86038 <1% 210 $2K
85730 <1% 425 $2K
97165 <1% 43 $2K
93880 <1% 22 $1K
83615 <1% 390 $1K
90715 <1% 335 $1K
0296T <1% 117 $1K
J3480 Injection, potassium chloride, per 2 meq <1% 92 $1K
76775 <1% 20 $1K
82550 <1% 314 $1K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 440 $1K
82950 <1% 300 $1K
87210 <1% 504 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 973 $1K
97014 <1% 55 $1K
L5695 Addition to lower extremity, above knee, pelvic control, sleeve suspension, neoprene or equal, each <1% 116 $1K
76536 <1% 13 $1K
87902 <1% 13 $1K
82565 <1% 336 $1K
88313 <1% 82 $990.19
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,929 $937.73
96367 <1% 38 $858.76
J2060 Injection, lorazepam, 2 mg <1% 1,262 $776.32
83970 <1% 33 $764.29
87075 <1% 159 $738.57
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 34 $686.10
85018 <1% 537 $680.41
84100 <1% 251 $664.06
97116 <1% 28 $660.94
A9270 Non-covered item or service <1% 6,134 $583.08
88312 <1% 50 $581.48
G0008 Administration of influenza virus vaccine <1% 559 $547.70
J7050 Infusion, normal saline solution, 250 cc <1% 170 $515.53
88304 <1% 29 $512.21
86706 <1% 66 $493.68
83655 <1% 49 $488.18
J1630 Injection, haloperidol, up to 5 mg <1% 103 $487.58
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results <1% 142 $476.64
90686 <1% 339 $472.76
P9612 Catheterization for collection of specimen, single patient, all places of service <1% 326 $466.32
80320 <1% 30 $445.00
74018 <1% 12 $413.33
82803 <1% 29 $404.28
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 110 $391.25
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 17 $327.87
J3475 Injection, magnesium sulfate, per 500 mg <1% 45 $312.10
85014 <1% 272 $311.46
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 2,051 $282.54
36416 <1% 354 $263.61
82570 <1% 69 $259.90
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 13 $248.13
84460 <1% 80 $243.30
84450 <1% 79 $233.31
J3370 Injection, vancomycin hcl, 500 mg <1% 35 $218.81
90662 <1% 249 $185.47
84520 <1% 105 $182.25
82105 <1% 12 $167.48
94664 <1% 29 $164.29
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 24 $156.26
94761 <1% 74 $152.73
86704 <1% 13 $150.06
80179 <1% 26 $148.29
A6213 Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing <1% 28 $140.78
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 16 $135.86
82947 <1% 34 $131.51
86431 <1% 24 $108.84
83721 <1% 27 $103.84
J1940 Injection, furosemide, up to 20 mg <1% 21 $90.31
90834 Psychotherapy session, about 45 minutes <1% 15 $78.72
94760 <1% 29 $75.41
84132 <1% 38 $73.46
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 25 $55.96
76999 <1% 14 $52.05
84156 <1% 16 $48.13
82248 <1% 22 $43.69
J2550 Injection, promethazine hcl, up to 50 mg <1% 43 $30.30
81015 <1% 20 $19.68
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 26 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 62 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 105 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTHERRIEN, ANDRE (CONTROLLER)
Same official

Other billing entities under THERRIEN, ANDRE

Full network →
ProviderLocationPaid
Catholic Medical CenterManchester, NH$465K
Catholic Medical CenterManchester, NH$134K
Catholic Medical CenterManchester, NH$677.30

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.